SCHEMBL19246261

SCHEMBL19246261

c1ccc(-c2nc(-n3c4ccccc4c4ccc5c6ccccc6oc5c43)nc3oc4ccccc4c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
MAPT P10636 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
SMN1; SMN2 Q16637 5/20 0.34
LMNA P02545 2/20 0.34
PTGER1 P34995 1/20 0.33
ALDH1A1 P00352 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HPGD P15428 3/20 0.31
POLB P06746 1/20 0.31
MAPK1 P28482 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN5 P54829 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19246321 0.89 SMN1; SMN2 (0.37) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19246251 0.88 SMN1; SMN2 (0.41) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL16905823 0.87 SMN1; SMN2 (0.40) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19246645 0.87 MEN1 (0.36) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19758351 0.87 MAPT (0.36) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19679711 0.87 MEN1 (0.33) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL22200014 0.87 MAPT (0.37) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19758379 0.86 MAPT (0.34) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL18505467 0.85 ALDH1A1 (0.45) MEN1KMT2ACSF1RPDGFRBMAPT
SCHEMBL19758314 0.85 MAPT (0.34) MEN1KMT2ACSF1RPDGFRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 MEN1 324/4885KMT2A 1197/4885CSF1R 1470/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 MEN1 324/4885KMT2A 1197/4885CSF1R 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.